Literature DB >> 30998966

LncRNA UCA1 protects cardiomyocytes against hypoxia/reoxygenation induced apoptosis through inhibiting miR-143/MDM2/p53 axis.

Qiang-Sheng Wang1, Jun Zhou2, Xun Li3.   

Abstract

BACKGROUND: lncUCA1 is abundantly expressed in the heart, indicating it may be important in maintaining normal myocardial function. However, the underlying mechanism of lncUCA1 in heart disease, particularly myocardial infarction (MI), is still in its infancy.
METHODS: LncUCA1 and miR-143 expression were measured in hearts of MI models. Overexpression and knockdown of lncUCA1 in neonatal rat cardiomyocytes were performed to confirm the effects of lncUCA1 in hypoxia-induced apoptosis.
RESULTS: The expression of lncUCA1 decreased but miR-143 increased inversely in MI heart. Overexpressing lncUCA1 protected cardiomyocytes from H/R induced apoptosis via inhibiting miR-143, which regulates apoptosis by targeting MDM2/p53 pathway. While silencing lncUCA1 caused miR-143 upregulation and H/R-induced apoptosis increase. Moreover, miR-143 was proved to be a competitive target of lncUCA1.
CONCLUSIONS: lncUCA1 might protect cardiomyocyte against H/R induced apoptosis by suppressing miR-143 and modulated the following downstream MDM2/p53 signaling pathway, indicating the therapeutic potential of targeting lncUCA1 for MI.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Hypoxia/reoxygenation; MDM2; lncUCA1; miR-143; p53

Year:  2019        PMID: 30998966     DOI: 10.1016/j.ygeno.2019.04.009

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  8 in total

1.  LncRNA-6395 promotes myocardial ischemia-reperfusion injury in mice through increasing p53 pathway.

Authors:  Lin-Feng Zhan; Qi Zhang; Lu Zhao; Xue Dong; Xin-Yu Pei; Li-Li Peng; Xiao-Wen Zhang; Bo Meng; Wen-di Shang; Zhen-Wei Pan; Chao-Qian Xu; Yan-Jie Lu; Ming-Yu Zhang
Journal:  Acta Pharmacol Sin       Date:  2021-09-07       Impact factor: 7.169

Review 2.  Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials.

Authors:  Yuncong Shi; Huanji Zhang; Suli Huang; Li Yin; Feng Wang; Pei Luo; Hui Huang
Journal:  Signal Transduct Target Ther       Date:  2022-06-25

3.  Conjoint analysis of lncRNA and mRNA expression in rotator cuff tendinopathy.

Authors:  Zilu Ge; Hong Tang; Jingtong Lyu; Binghua Zhou; Mingyu Yang; Kanglai Tang; Wan Chen
Journal:  Ann Transl Med       Date:  2020-03

4.  Transfer of lncRNA UCA1 by hUCMSCs-derived exosomes protects against hypoxia/reoxygenation injury through impairing miR-143-targeted degradation of Bcl-2.

Authors:  Liwei Diao; Qinghua Zhang
Journal:  Aging (Albany NY)       Date:  2021-02-11       Impact factor: 5.682

5.  Urothelial Cancer Associated 1 (UCA1) and miR-193 Are Two Non-coding RNAs Involved in Trophoblast Fusion and Placental Diseases.

Authors:  Clara Apicella; Camino S M Ruano; Sébastien Jacques; Géraldine Gascoin; Céline Méhats; Daniel Vaiman; Francisco Miralles
Journal:  Front Cell Dev Biol       Date:  2021-05-13

6.  CircMCTP2 (has-circ-0000658) facilitates the proliferation and metastasis of bladder carcinoma through modulating the miR-498/murine double minute-2 axis.

Authors:  Qiao Gu; Wenjie Hou; Lijuan Shi; Zonghao Zhu; Huan Liu; Xiaozhou He
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

Review 7.  Recent advances on the roles of LncRNAs in cardiovascular disease.

Authors:  Yexian Fang; Yuerong Xu; Runze Wang; Lang Hu; Dong Guo; Feng Xue; Wangang Guo; Dongwei Zhang; Jianqiang Hu; Yan Li; Wei Zhang; Mingming Zhang
Journal:  J Cell Mol Med       Date:  2020-09-24       Impact factor: 5.310

Review 8.  The Regulation Mechanisms and Clinical Application of MicroRNAs in Myocardial Infarction: A Review of the Recent 5 Years.

Authors:  Chan Wu; Binghong Liu; Ruiying Wang; Gang Li
Journal:  Front Cardiovasc Med       Date:  2022-01-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.